Evidence-Based Updates & Advocacy
On November 23, 2023, Lancet Psychiatry published a meta-analysis delving into the critical issue of ADHD medication discontinuation and persistence across diverse age groups and… Continue Reading ADHD Medication Discontinuation: An In-depth Analysis
A Global Gathering for ADHD Advancements The American Professional Society for ADHD and Related Disorders (APSARD) 2024 conference served as a pivotal moment, bringing together… Continue Reading Insights at the APSARD 2024 Conference
Exposing the serious consequences of undiagnosed ADHD, this narrative calls urgently for early intervention. Unveil the shadows, protect vulnerable lives. Shadows of Undiagnosed ADHD In… Continue Reading Serious Consequences of Undiagnosed ADHD
David Goggins, renowned for his extraordinary accomplishments like running 100 miles in under 24 hours, is dispelling the notion that his running prowess stems from… Continue Reading Breaking Barriers: Goggins opens up about ADHD
ADHD Overview: Common developmental stages may include focus and impulse control issues. ADHD is a chronic condition affecting 7.6% of children aged 3-12 and 5.6%… Continue Reading Role of Parent training: CONNECTION BEFORE CORRECTION
I fail to understand, why As someone who is currently undergoing trial and error of apt therapy, there seems an addressed disparity of medicine accessibility!… Continue Reading ADHD Medication Lag in India
In the top-down attention circuits, those directing discipline, organization, inhibiting distractions! Reference:Arnsten AF. The Emerging Neurobiology of Attention Deficit Hyperactivity Disorder: The Key Role of… Continue Reading Where is ADHD???
At the ASPARD conference, a poster was presented: Substance Use Motives and Patterns in People With and Without ADHD Key Findings Treatment of ADHD did… Continue Reading 6 Key Differences in Substance Use Patterns of ADHDers and Implications
